Pharmafile Logo

Health Behaviour Change

- PMLiVE

TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH

It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...

Medscape Education Global

- PMLiVE

Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2.8bn

The agreement builds on the companies’ peptide-drug conjugate collaboration announced in 2019

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu shows promise in phase 3 breast cancer study

More than two million cases of breast cancer were diagnosed globally in 2022

- PMLiVE

UK study reveals significantly higher risk of second cancers among breast cancer survivors

Breast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually

- PMLiVE

Data integration and the AI healthcare revolution

Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK

- PMLiVE

Hope in cancer therapy

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

Springer Nature

- PMLiVE

Health awareness days in May

Are you marketing to clinical audiences around upcoming health awareness days?

Springer Nature

- PMLiVE

Why Women in Medicine Should Embrace Social Media

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...

Medscape Education Global

- PMLiVE

Bristol Myers Squibb and Repertoire enter autoimmune disease partnership worth over $1.8bn

It is estimated that up to 50 million people in the US have an autoimmune disease

- PMLiVE

Takeda’s fruquintinib recommended by CHMP for metastatic colorectal cancer

Approximately 520,000 new cases of colorectal cancer were diagnosed in Europe in 2020

- PMLiVE

Merck’s adult-specific pneumococcal vaccine shows promise in late-stage study

There are more than 100 types of pneumococcal bacteria, which can affect adults differently than children

- PMLiVE

Thinking differently

Exploring the benefits of welcoming neurodiversity across the healthcare communications industry

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links